These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3767483)

  • 1. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids.
    Halebian PH; Corder VJ; Madden MR; Finklestein JL; Shires GT
    Ann Surg; 1986 Nov; 204(5):503-12. PubMed ID: 3767483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of patients with toxic epidermal necrolysis syndrome revisited.
    Ducic I; Shalom A; Rising W; Nagamoto K; Munster AM
    Plast Reconstr Surg; 2002 Sep; 110(3):768-73. PubMed ID: 12172137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
    McCullough M; Burg M; Lin E; Peng D; Garner W
    Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
    Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 10-year experience with toxic epidermal necrolysis.
    Schulz JT; Sheridan RL; Ryan CM; MacKool B; Tompkins RG
    J Burn Care Rehabil; 2000; 21(3):199-204. PubMed ID: 10850900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological findings and antibacterial therapy in Stevens-Johnson syndrome/toxic epidermal necrolysis patients from a Swedish Burn Center.
    Tocco-Tussardi I; Huss F; Presman B
    J Cutan Pathol; 2017 May; 44(5):420-432. PubMed ID: 28075032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic epidermal necrolysis and Stevens-Johnson syndrome at the Prague Burn Centre 1998-2008.
    Zajicek R; Pintar D; Broz L; Suca H; Königova R
    J Eur Acad Dermatol Venereol; 2012 May; 26(5):639-43. PubMed ID: 21668825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of Stevens-Johnson syndrome/toxic epidermal necrolysis treated with corticosteroids.
    Liu W; Nie X; Zhang L
    Int J Dermatol; 2016 Dec; 55(12):1408-1413. PubMed ID: 27652522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a university hospital.
    Ferrándiz-Pulido C; García-Fernández D; Domínguez-Sampedro P; García-Patos V
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1153-9. PubMed ID: 21198948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of nonstaphylococcal toxic epidermal necrolysis: follow-up study of 16 case histories.
    Tegelberg-Stassen MJ; van Vloten WA; Baart de la Faille H
    Dermatologica; 1990; 180(3):124-9. PubMed ID: 2187719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study.
    Schneck J; Fagot JP; Sekula P; Sassolas B; Roujeau JC; Mockenhaupt M
    J Am Acad Dermatol; 2008 Jan; 58(1):33-40. PubMed ID: 17919775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of ocular conditions in the burn unit: thermal and chemical burns and Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Lin A; Patel N; Yoo D; DeMartelaere S; Bouchard C
    J Burn Care Res; 2011; 32(5):547-60. PubMed ID: 21799437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroids in toxic epidermal necrolysis.
    Pasricha JS
    Indian J Dermatol Venereol Leprol; 2008; 74(5):493; author reply 493-5. PubMed ID: 19052413
    [No Abstract]   [Full Text] [Related]  

  • 20. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.